Navigation path

Additional tools

    Profile of registrant

Pfizer Inc.

Identification number in the register: 4263301811-33
Registration date: 18/12/2008 10:25:52

The information on this entity was last modified on: 17/01/2017 09:24:38
The date of the last annual update was: 17/01/2017 09:24:38
Next update due latest on: 17/01/2018

    Registrant : Organisation or self-employed individual

Pfizer Inc.



    Section of registration

II - In-house lobbyists and trade/business/professional associations

Companies & groups

    Contact details

East 42nd Street, 235
New York NY 10017


Boulevard de la Plaine 17
Brussels 1050


    Person with legal responsibility

Mr  Ian C. Read


    Person in charge of EU relations

Ms  Eva Grut-Aandahl

Head of EU Office

    Goals / remit

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. In 2015, Pfizer's full year revenue was $ 48,851bn, with approx. 10% invested in research and development.To learn more, please visit us at


    Specific activities covered by the Register

Healthcare and pharmaceutical legislation, Trade & IP, competition, taxation, environment, social legislation

None foreseen




EU expert group on rare diseases (as representative of EuropaBio)



Pharmaceuticals, healthcare, innovation and research, intellectual property, business competitiveness, trade, environment

    Number of persons involved in the activities described in the box above

50%: 3   25%: 2



3 colleagues are full-time engaged in the Brussels office and spend approx. 50% of their time on EU affairs. Moreover, 2 other colleagues spend about 25% of their time or less, and a number of colleagues spend between 0-10%< of their time.

    Persons accredited for access to European Parliament premises

First name Surname Start Date End Date
Eva Grut AANDAHL 21/02/2017 13/02/2018
ANDREA CHIARELLO 30/09/2016 28/09/2017
Matthew Thomas CLAY 23/01/2017 11/01/2018
Charles FAID 21/02/2017 14/02/2018
Heike GALBRAITH 21/02/2017 14/02/2018

    Fields of interest

  • Competition
  • Consumer Affairs
  • Customs
  • Economic and Financial Affairs
  • Enterprise
  • Environment
  • External Relations
  • Humanitarian Aid
  • Internal Market
  • Justice and Fundamental Rights
  • Public Health
  • Research and Technology
  • Taxation
  • Trade

    Membership and affiliation


In 2016 Pfizer was a member of: EFPIA, EBE, Vaccines Europe, EuropaBio, AESGP, Amcham EU, BusinessEurope, TPN, TABC, AECA

    Financial data

12/2015  -  12/2016

900,000 € - 999,999 €

No funding received from the EU institutions during the last closed financial year.

This estimate is based on a percentage of the salaries of the staffers falling under the scope of the Register, and a percentage of the overall costs of running an office in Brussels, based on the proportion of employee time spent on these activities.
We have included 100% of consultancy costs, and a proportion of member association fees as indicated in guidelines.

    Code of conduct

By its registration the organisation has signed the Transparency Register Code of Conduct.

The organisation has also declared to be bound to the following other Code:
Internal Pfizer FCPA Code and Compliance, EFPIA Codes